COMMUNIQUÉS West-GlobeNewswire

Skin Care & Laser Physicians of Beverly Hills Expands Physician Availability for Patients
02/08/2019
Board-certified dermatologist Dr. Ardalan Minokadeh joined the Los Angeles-area team full time in May BEVERLY HILLS, Cal., Aug. 02, 2019 (GLOBE NEWSWIRE) -- The Skin Care & Laser Physicians of Beverly Hills team [...]
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
02/08/2019
SAN DIEGO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
Resverlogix Announces Loan Reduction and Extension
02/08/2019
Loan reduced from US$30 million to US$11.5 million CALGARY, Alberta, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an amending [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2019
02/08/2019
Paris, le 2 août 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
Information on total number of voting rights and shares composing the share capital as at July 31st, 2019
02/08/2019
Paris, August 2 nd , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
02/08/2019
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France LYON, France, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Juillet 2019
02/08/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France LYON, France, 02 août 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
02/08/2019
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019 LYON, France, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Juillet 2019
02/08/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 02 août 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]
AB Science today reports the analysis for its phase 3 trial evaluating masitinib in patients with non-resectable or metastatic stage 3 or stage 4 melanoma
02/08/2019
Paris, August 2, 2019, 5.30pm AB Science announces new clinical results in oncology: Masitinib showed activity in metastatic melanoma bearing the juxta-membrane mutation of c-Kit AB Science SA (NYSE Euronext - [...]
AB Science annonce aujourd’hui les résultats de son étude de phase 3 évaluant le masitinib chez des patients atteints de mélanome non opérable ou métastatique de stade 3 ou stade 4
02/08/2019
Paris, 2 août 2019, 17h30 AB Science annonce de nouveaux résultats cliniques en oncologie : L’activité du masitinib a été démontrée dans le mélanome métastatique présentant une mutation du domaine juxta-membranaire de c [...]
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
02/08/2019
Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) announced today that it intends to delist its American Depositary Shares (“ADS”) from the Nasdaq Capital Market (“NASDAQ”) and to deregister and terminate its [...]
Ecomed Solutions Receives Innovative Technology Contract from Vizient for Its Novel Blood Management Device, HEMAsavR™
02/08/2019
MUNDELEIN, Ill., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Ecomed Solutions , the developer and manufacturer of innovative healthcare solutions, announced its HEMAsavR ™ has received an Innovative Technology contract from [...]
BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
02/08/2019
SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the [...]
Wildflower Brands Closes on Private Placement
02/08/2019
VANCOUVER, British Columbia,, Aug. 02, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN) (the “Company”) wishes to announce it has received subscriptions for a convertible debenture financing [...]
Predictive Laboratories to Present New Endometriosis Discoveries in Three Presentations at Leading Scientific Conference Focused on Human Infertility
02/08/2019
American Society of Reproductive Medicine selects findings through scientific peer-review process for presentations at the 75th ASRM Scientific Congress & Expo in October SALT LAKE CITY, Aug. 02, 2019 (GLOBE [...]
Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8
02/08/2019
LONDON, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release [...]
Agile Therapeutics Announces Pricing of $12 Million Underwritten Public Offering of Common Stock
02/08/2019
PRINCETON, N.J., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 12,631,579 shares of its [...]
Alphatec to Present at the Canaccord Genuity 39th Annual Growth Conference
02/08/2019
CARLSBAD, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine [...]

Pages